Haverford Trust CO Abbott Laboratories Transaction History

Haverford Trust CO

  • $10.2 Billion
  • Q3 2024

A detailed history of Haverford Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Haverford Trust CO holds 99,364 shares of ABT stock, worth $11.4 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
99,364
Previous 99,998 0.63%
Holding current value
$11.4 Million
Previous $10.4 Million 9.03%
% of portfolio
0.11%
Previous 0.11%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$100.07 - $118.13 $63,444 - $74,894
-634 Reduced 0.63%
99,364 $11.3 Million
Q2 2024

Aug 13, 2024
BUY
$100.73 - $112.44 $115,638 - $129,081
1,148 Added 1.16%
99,998 $10.4 Million
Q1 2024

May 02, 2024
BUY
$109.52 - $120.96 $544,423 - $601,292
4,971 Added 5.3%
98,850 $11.2 Million
Q4 2023

Feb 08, 2024
BUY
$90.19 - $110.4 $59,886 - $73,305
664 Added 0.71%
93,879 $10.3 Million
Q3 2023

Nov 09, 2023
SELL
$95.53 - $114.62 $61,234 - $73,471
-641 Reduced 0.68%
93,215 $9.03 Million
Q2 2023

Aug 08, 2023
BUY
$100.78 - $112.29 $304,657 - $339,452
3,023 Added 3.33%
93,856 $10.2 Million
Q1 2023

May 12, 2023
BUY
$96.86 - $114.01 $306,077 - $360,271
3,160 Added 3.6%
90,833 $9.2 Million
Q4 2022

Feb 13, 2023
SELL
$95.06 - $111.52 $220,063 - $258,168
-2,315 Reduced 2.57%
87,673 $9.63 Million
Q3 2022

Nov 14, 2022
BUY
$96.76 - $112.03 $95,792 - $110,909
990 Added 1.11%
89,988 $8.71 Million
Q2 2022

Aug 12, 2022
SELL
$102.07 - $123.37 $279,161 - $337,416
-2,735 Reduced 2.98%
88,998 $9.67 Million
Q1 2022

May 05, 2022
BUY
$114.02 - $139.04 $219,716 - $267,930
1,927 Added 2.15%
91,733 $10.9 Million
Q4 2021

Feb 14, 2022
BUY
$115.53 - $141.46 $64,812 - $79,359
561 Added 0.63%
89,806 $12.6 Million
Q3 2021

Nov 12, 2021
SELL
$116.66 - $129.06 $468,273 - $518,046
-4,014 Reduced 4.3%
89,245 $10.5 Million
Q2 2021

Aug 16, 2021
BUY
$105.79 - $124.53 $8.72 Million - $10.3 Million
82,447 Added 762.55%
93,259 $10.8 Million
Q2 2021

Aug 16, 2021
SELL
$105.79 - $124.53 $8.31 Million - $9.78 Million
-78,552 Reduced 87.9%
10,812 $10.8 Million
Q1 2021

May 12, 2021
BUY
$108.84 - $128.23 $930,582 - $1.1 Million
8,550 Added 10.58%
89,364 $10.7 Million
Q4 2020

Feb 05, 2021
BUY
$105.0 - $114.42 $530,460 - $578,049
5,052 Added 6.67%
80,814 $8.85 Million
Q3 2020

Nov 10, 2020
SELL
$91.64 - $111.29 $265,572 - $322,518
-2,898 Reduced 3.68%
75,762 $8.25 Million
Q2 2020

Aug 13, 2020
BUY
$76.57 - $98.0 $87,978 - $112,602
1,149 Added 1.48%
78,660 $7.19 Million
Q1 2020

May 11, 2020
SELL
$62.82 - $91.86 $327,292 - $478,590
-5,210 Reduced 6.3%
77,511 $6.12 Million
Q4 2019

Feb 10, 2020
SELL
$78.51 - $87.4 $55,820 - $62,141
-711 Reduced 0.85%
82,721 $7.19 Million
Q3 2019

Nov 04, 2019
SELL
$81.84 - $88.74 $484,329 - $525,163
-5,918 Reduced 6.62%
83,432 $6.98 Million
Q2 2019

Aug 13, 2019
SELL
$72.88 - $85.0 $97,367 - $113,560
-1,336 Reduced 1.47%
89,350 $7.51 Million
Q1 2019

May 09, 2019
BUY
$66.22 - $80.06 $55,955 - $67,650
845 Added 0.94%
90,686 $7.25 Million
Q4 2018

Feb 12, 2019
BUY
$65.56 - $74.27 $262,830 - $297,748
4,009 Added 4.67%
89,841 $6.5 Million
Q3 2018

Nov 08, 2018
BUY
$60.81 - $73.36 $28,763 - $34,699
473 Added 0.55%
85,832 $6.3 Million
Q2 2018

Aug 10, 2018
SELL
$57.57 - $63.54 $31,030 - $34,248
-539 Reduced 0.63%
85,359 $5.21 Million
Q1 2018

May 09, 2018
BUY
$56.27 - $63.62 $6,696 - $7,570
119 Added 0.14%
85,898 $5.15 Million
Q4 2017

Feb 13, 2018
BUY
$53.68 - $57.47 $234,688 - $251,258
4,372 Added 5.37%
85,779 $4.9 Million
Q3 2017

Nov 09, 2017
BUY
$48.06 - $53.64 $137,307 - $153,249
2,857 Added 3.64%
81,407 $4.34 Million
Q2 2017

Aug 14, 2017
BUY
N/A
78,550
78,550 $3.82 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Haverford Trust CO Portfolio

Follow Haverford Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Haverford Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Haverford Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email